Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2020-02-26 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
关于召开2020年第一次临时股东大会通知的公告
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about the convening of the 2020 first extraordinary general meeting (临时股东大会) of 康芝药业股份有限公司. It includes information about the meeting date, location, voting procedures (both onsite and online), agenda items (notably a proposal to amend the company articles of association), registration procedures, and proxy authorization forms. There are no financial statements, earnings data, or audit information present. The document is not a report but a formal announcement and invitation to shareholders to attend and vote at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-02-26 Chinese
关于修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement from 康芝药业股份有限公司 regarding the modification of the company's Articles of Association (公司章程). It details specific changes to the company's business scope and the corresponding amendments to Article 16 of the Articles of Association. The document states that the changes will be submitted to the shareholders' meeting for approval and that the updated Articles will be filed with the market supervision authority. There is no financial data, no audit information, no earnings or quarterly report content, nor is it a call transcript or voting result announcement. The document is a formal announcement about governance changes, specifically the company's internal rules and structure (Articles of Association). Therefore, the most appropriate classification is Governance Information (CGR). The document length is short and it is not merely announcing the publication of a report but providing substantive content about governance changes.
2020-02-26 Chinese
第五届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the company's fifth board meeting, including decisions on investment, appointment of an audit department head, amendments to the company charter, and scheduling a shareholders' meeting. It contains no financial statements or detailed financial data. It is a formal disclosure of board decisions and management changes, specifically the appointment of a senior audit official. This fits the category of Board/Management Information (MANG). The document length is short (1842 characters), and it is not a report or financial statement but an announcement of board resolutions and management appointments.
2020-02-26 Chinese
公司章程（2020年2月）
Governance Information Classification · 100% confidence The document is titled as the "公司章程" which translates to "Company Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board structure, management, financial accounting, and other governance-related rules. It includes chapters on shareholders, shareholder meetings, board of directors, senior management, supervisory board, financial accounting, profit distribution, auditing, notices and announcements, mergers, capital changes, and amendments to the articles. There is no financial data, earnings information, audit reports, or regulatory filings of financial results. Instead, it is a governance document outlining the internal rules and structure of the company. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial and contains the full text of the articles, not just an announcement or summary, so it is not a report publication announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2020-02-26 Chinese
关于公司与广州高新区投资集团有限公司及合景健康产业集团有限公司签署战略合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a strategic cooperation agreement between Kangzhi Pharmaceutical Co., Ltd., Guangzhou High-tech Zone Investment Group Co., Ltd., and Hejing Health Industry Group Co., Ltd. It details the background, parties involved, cooperation goals, content, and risk warnings. The document explicitly states that the agreement is an intention framework without specific financial commitments or resource transfers, and it does not constitute a major asset restructuring. It is a formal announcement of a strategic cooperation agreement rather than a full report or financial statement. There is no financial data, earnings information, or detailed management discussion. The document is a regulatory announcement informing shareholders and the public about the strategic cooperation agreement and its implications. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-02-24 Chinese
关于控股股东部分股权解除质押及再质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge and re-pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company shares, the purpose of the pledge, and risk disclosures. It includes financial data of the controlling shareholder but does not contain comprehensive financial statements or detailed financial performance of the company. The document is a regulatory announcement about share pledging activities by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is 4516 characters, which is consistent with a detailed announcement but not a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. Therefore, the best classification is Major Shareholding Notification (MRQ).
2020-02-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.